Quite an expensive settlement, but a settlement
26/06/20 -"We have taken into account the guided cash out in 2020 and 2021 for the announced settlements of the three litigations. Regarding the 15% tax shield Bayer also guided for, we remain rather more ..."
Pages
76
Language
English
Published on
26/06/20
You may also be interested by these reports :
14/08/20
Novozymes reported largely in line Q2 20 numbers as sales were down 2% (in line with the trading update) and the EBIT margin came in at 25.9% (-10bp ...
13/08/20
Despite being slightly impacted by COVID-19 in Q2, Darzalex continued to gain share in the multiple myeloma market. Given the encouraging launch of ...
13/08/20
Population confinement measures adversely impacted plasma collection volumes (especially in the US), leading to higher plasma collection costs and ...
10/08/20
Hikma’s H1 20 top-line acceleration was driven by COVID-19-related demand in Injectables and Generics and the economic recovery in Algeria propelled ...